Endorphins

Last updated

Endorphins (contracted from endogenous morphine) [1] [2] [3] are peptides produced in the brain that block the perception of pain and increase feelings of wellbeing. They are produced and stored in the pituitary gland of the brain. Endorphins are endogenous painkillers often produced in the brain and adrenal medulla during physical exercise or orgasm and inhibit pain, muscle cramps, and relieve stress. [4] [5] [6] [7]

Contents

History

Opioid peptides in the brain were first discovered in 1973 by investigators at the University of Aberdeen, John Hughes and Hans Kosterlitz. They isolated "enkephalins" (from the Greek εγκέφαλος, cerebrum) from pig brain, identified as Met-enkephalin and Leu-enkephalin. [8] [9] [10] [11] This came after the discovery of a receptor that was proposed to produce the pain-relieving analgesic effects of morphine and other opioids, which led Kosterlitz and Hughes to their discovery of the endogenous opioid ligands. [11] Research during this time was focused on the search for a painkiller that did not have the addictive character or overdose risk of morphine. [11] [12]

Rabi Simantov and Solomon H. Snyder isolated morphine-like peptides from calf brain. [13] Eric J. Simon, who independently discovered opioid receptors, later termed these peptides as endorphins. [14] This term was essentially assigned to any peptide that demonstrated morphine-like activity. [15] In 1976, Choh Hao Li and David Chung recorded the sequences of α-, β-, and γ-endorphin isolated from camel pituitary glands for their opioid activity. [16] [17] Li determined that β-endorphin produced strong analgesic effects. [18] Wilhelm Feldberg and Derek George Smyth in 1977 confirmed this, finding β-endorphin to be more potent than morphine. They also confirmed that its effects were reversed by naloxone, an opioid antagonist. [19]

Studies have subsequently distinguished between enkephalins, endorphins, and endogenously produced morphine, [20] [21] which is not a peptide. Opioid peptides are classified based on their precursor propeptide: all endorphins are synthesized from the precursor proopiomelanocortin (POMC), encoded by proenkephalin A, and dynorphins encoded by pre-dynorphin. [12] [22]

Etymology

The word endorphin is derived from ἔνδον / Greek : éndon meaning "within" (endogenous, ἐνδογενής / Greek : endogenes, "proceeding from within"), and morphine, from Morpheus (Ancient Greek : Μορφεύς, romanized: Morpheús), the god of dreams in the Greek mythology. Thus, endorphin is a contraction of 'endo(genous) (mo)rphin' (morphin being the old spelling of morphine).

Types

The class of endorphins consists of three endogenous opioid peptides: α-endorphin, β-endorphin, and γ-endorphin. [23] The endorphins are all synthesized from the precursor protein, proopiomelanocortin, and all contain a Met-enkephalin motif at their N-terminus: Tyr-Gly-Gly-Phe-Met. [12] α-endorphin and γ-endorphin result from proteolytic cleavage of β-endorphin between the Thr(16)-Leu(17) residues and Leu(17)-Phe(18) respectively. [24] α-endorphin has the shortest sequence, and β-endorphin has the longest sequence.

α-endorphin and γ-endorphin are primarily found in the anterior and intermediate pituitary. [25] While β-endorphin is studied for its opioid activity, α-endorphin and γ-endorphin both lack affinity for opiate receptors and thus do not affect the body in the same way that β-endorphin does. Some studies have characterized α-endorphin activity as similar to that of psychostimulants and γ-endorphin activity to that of neuroleptics separately. [25]

NameSequenceReference
α-endorphin Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-OH [26] [12]
β-endorphin Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala-Tyr-Lys-Lys-Gly-Glu [27] [28]
γ-endorphin Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-OH [26] [12]

Synthesis

Endorphin precursors are primarily produced in the pituitary gland. [29] [30] [31] All three types of endorphins are fragments of the precursor protein proopiomelanocortin (POMC). At the trans-Golgi network, POMC binds to a membrane-bound protein, carboxypeptidase E (CPE). [32] CPE facilitates POMC transport into immature budding vesicles. [33] In mammals, pro-peptide convertase 1 (PC1) cleaves POMC into adrenocorticotropin (ACTH) and beta-lipotropin (β-LPH). [32] β-LPH, a pituitary hormone with little opiate activity, is then continually fragmented into different peptides, including α-endorphin, β-endorphin, and γ-endorphin. [28] [34] [35] Peptide convertase 2 (PC2) is responsible for cleaving β-LPH into β-endorphin and γ-lipotropin. [12] Formation of α-endorphin and γ-endorphin results from proteolytic cleavage of β-endorphin. [24]

Regulation

Noradrenaline has been shown to increase endorphins production within inflammatory tissues, resulting in an analgesic effect; [36] the stimulation of sympathetic nerves by electro-acupuncture is believed to be the cause of its analgesic effects. [37]

Mechanism of action

Endorphins are released from the pituitary gland, typically in response to pain, and can act in both the central nervous system (CNS) and the peripheral nervous system (PNS). In the PNS, β-endorphin is the primary endorphin released from the pituitary gland. Endorphins inhibit transmission of pain signals by binding μ-receptors of peripheral nerves, which block their release of neurotransmitter substance P. The mechanism in the CNS is similar but works by blocking a different neurotransmitter: gamma-aminobutyric acid (GABA). In turn, inhibition of GABA increases the production and release of dopamine, a neurotransmitter associated with reward learning. [27] [38]

Functions

Endorphins play a major role in the body's inhibitory response to pain. Research has demonstrated that meditation by trained individuals can be used to trigger endorphin release. [39] [ failed verification ] Laughter may also stimulate endorphin production and elevate one's pain threshold. [40]

Endorphin production can be triggered by vigorous aerobic exercise. The release of β-endorphin has been postulated to contribute to the phenomenon known as "runner's high". [41] [42] However, several studies have supported the hypothesis that the runner's high is due to the release of endocannabinoids rather than that of endorphins. [43] Endorphins may contribute to the positive effect of exercise on anxiety and depression. [44] The same phenomenon may also play a role in exercise addiction. Regular intense exercise may cause the brain to downregulate the production of endorphins in periods of rest to maintain homeostasis, causing a person to exercise more intensely in order to receive the same feeling. [45]

Related Research Articles

<span class="mw-page-title-main">Proopiomelanocortin</span> Mammalian protein found in Homo sapiens

Pro-opiomelanocortin (POMC) is a precursor polypeptide with 241 amino acid residues. POMC is synthesized in corticotrophs of the anterior pituitary from the 267-amino-acid-long polypeptide precursor pre-pro-opiomelanocortin (pre-POMC), by the removal of a 26-amino-acid-long signal peptide sequence during translation. POMC is part of the central melanocortin system.

<span class="mw-page-title-main">Opioid</span> Psychoactive chemical

Opioids are a class of drugs that derive from, or mimic, natural substances found in the opium poppy plant. Opioids work in the brain to produce a variety of effects, including pain relief. As a class of substances, they act on opioid receptors to produce morphine-like effects.

The melanocyte-stimulating hormones, known collectively as MSH, also known as melanotropins or intermedins, are a family of peptide hormones and neuropeptides consisting of α-melanocyte-stimulating hormone (α-MSH), β-melanocyte-stimulating hormone (β-MSH), and γ-melanocyte-stimulating hormone (γ-MSH) that are produced by cells in the pars intermedia of the anterior lobe of the pituitary gland.

<span class="mw-page-title-main">Opioid receptor</span> Group of biological receptors

Opioid receptors are a group of inhibitory G protein-coupled receptors with opioids as ligands. The endogenous opioids are dynorphins, enkephalins, endorphins, endomorphins and nociceptin. The opioid receptors are ~40% identical to somatostatin receptors (SSTRs). Opioid receptors are distributed widely in the brain, in the spinal cord, on peripheral neurons, and digestive tract.

<span class="mw-page-title-main">Enkephalin</span> Pentapeptide

An enkephalin is a pentapeptide involved in regulating nociception in the body. The enkephalins are termed endogenous ligands, as they are internally derived and bind to the body's opioid receptors. Discovered in 1975, two forms of enkephalin have been found, one containing leucine ("leu"), and the other containing methionine ("met"). Both are products of the proenkephalin gene.

β-Endorphin Peptide hormone in humans

β-Endorphin (beta-endorphin) is an endogenous opioid neuropeptide and peptide hormone that is produced in certain neurons within the central nervous system and peripheral nervous system. It is one of three endorphins that are produced in humans, the others of which include α-endorphin and γ-endorphin.

<span class="mw-page-title-main">Periaqueductal gray</span> Nucleus surrounding the cerebral aqueduct

The periaqueductal gray is a brain region that plays a critical role in autonomic function, motivated behavior and behavioural responses to threatening stimuli. PAG is also the primary control center for descending pain modulation. It has enkephalin-producing cells that suppress pain.

<span class="mw-page-title-main">Opioid peptide</span> Class of peptides that bind to opioid receptors

Opioid peptides or opiate peptides are peptides that bind to opioid receptors in the brain; opiates and opioids mimic the effect of these peptides. Such peptides may be produced by the body itself, for example endorphins. The effects of these peptides vary, but they all resemble those of opiates. Brain opioid peptide systems are known to play an important role in motivation, emotion, attachment behaviour, the response to stress and pain, control of food intake, and the rewarding effects of alcohol and nicotine.

Lipotropin is the name for two hormones produced by the cleavage of pro-opiomelanocortin (POMC). The anterior pituitary gland produces the pro-hormone POMC, which is then cleaved again to form adrenocorticotropin (ACTH) and β-lipotropin (β-LPH).

<span class="mw-page-title-main">Endomorphin</span> Chemical compound

Endomorphins are considered to be natural opioid neurotransmitters central to pain relief. The two known endomorphins, endomorphin-1 and endomorphin-2, are tetrapeptides, consisting of Tyr-Pro-Trp-Phe and Tyr-Pro-Phe-Phe amino acid sequences respectively. These sequences fold into tertiary structures with high specificity and affinity for the μ-opioid receptor, binding it exclusively and strongly. Bound μ-opioid receptors typically induce inhibitory effects on neuronal activity. Endomorphin-like immunoreactivity exists within the central and peripheral nervous systems, where endomorphin-1 appears to be concentrated in the brain and upper brainstem, and endomorphin-2 in the spinal cord and lower brainstem. Because endomorphins activate the μ-opioid receptor, which is the target receptor of morphine and its derivatives, endomorphins possess significant potential as analgesics with reduced side effects and risk of addiction.

<span class="mw-page-title-main">Met-enkephalin</span> Chemical compound

Met-enkephalin, also known as metenkefalin (INN), sometimes referred to as opioid growth factor (OGF), is a naturally occurring, endogenous opioid peptide that has opioid effects of a relatively short duration. It is one of the two forms of enkephalin, the other being leu-enkephalin. The enkephalins are considered to be the primary endogenous ligands of the δ-opioid receptor, due to their high potency and selectivity for the site over the other endogenous opioids.

μ-opioid receptor Protein-coding gene in the species Homo sapiens, named for its ligand morphine

The μ-opioid receptors (MOR) are a class of opioid receptors with a high affinity for enkephalins and beta-endorphin, but a low affinity for dynorphins. They are also referred to as μ(mu)-opioid peptide (MOP) receptors. The prototypical μ-opioid receptor agonist is morphine, the primary psychoactive alkaloid in opium and for which the receptor was named, with mu being the first letter of Morpheus, the compound's namesake in the original Greek. It is an inhibitory G-protein coupled receptor that activates the Gi alpha subunit, inhibiting adenylate cyclase activity, lowering cAMP levels.

<span class="mw-page-title-main">Nociceptin receptor</span> Protein-coding gene in the species Homo sapiens

The nociceptin opioid peptide receptor (NOP), also known as the nociceptin/orphanin FQ (N/OFQ) receptor or kappa-type 3 opioid receptor, is a protein that in humans is encoded by the OPRL1 gene. The nociceptin receptor is a member of the opioid subfamily of G protein-coupled receptors whose natural ligand is the 17 amino acid neuropeptide known as nociceptin (N/OFQ). This receptor is involved in the regulation of numerous brain activities, particularly instinctive and emotional behaviors. Antagonists targeting NOP are under investigation for their role as treatments for depression and Parkinson's disease, whereas NOP agonists have been shown to act as powerful, non-addictive painkillers in non-human primates.

Leu-enkephalin is an endogenous opioid peptide neurotransmitter with the amino acid sequence Tyr-Gly-Gly-Phe-Leu that is found naturally in the brains of many animals, including humans. It is one of the two forms of enkephalin; the other is met-enkephalin. The tyrosine residue at position 1 is thought to be analogous to the 3-hydroxyl group on morphine. Leu-enkephalin has agonistic actions at both the μ- and δ-opioid receptors, with significantly greater preference for the latter. It has little to no effect on the κ-opioid receptor.

DAMGO is a synthetic opioid peptide with high μ-opioid receptor specificity. It was synthesized as a biologically stable analog of δ-opioid receptor-preferring endogenous opioids, leu- and met-enkephalin. Structures of DAMGO bound to the µ opioid receptor reveal a very similar binding pose to morphinans.

<span class="mw-page-title-main">RB-101</span> Chemical compound

RB-101 is a drug that acts as an enkephalinase inhibitor, which is used in scientific research.

α-Endorphin Chemical compound

α-Endorphin (alpha-endorphin) is an endogenous opioid peptide with a length of 16 amino acids, and the amino acid sequence: Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr. With the use of mass spectrometry, Nicholas Ling was able to determine the primary sequence of a-endorphin.

Neoendorphins are a group of endogenous opioid peptides derived from the proteolytic cleavage of prodynorphin. They include α-neoendorphin and β-neoendorphin. The α-neoendorphin is present in greater amounts in the brain than β-neoendorphin. Both are products of the dynorphin gene, which also expresses dynorphin A, dynorphin A-(1-8), and dynorphin B. These opioid neurotransmitters are especially active in Central Nervous System receptors, whose primary function is pain sensation. These peptides all have the consensus amino acid sequence of Try-Gly-Gly-Phe-Met (met-enkephalin) or Tyr-Gly-Gly-Phe-Leu ( leu-enkephalin). Binding of neoendorphins to opioid receptors (OPR), in the dorsal root ganglion (DRG) neurons results in the reduction of time of calcium-dependent action potential. The α-neoendorphins bind OPRD1(delta), OPRK1(kappa), and OPRM1 (mu) and β-neoendorphin bind OPRK1.

<span class="mw-page-title-main">Huda Akil</span> Syrian–American neuroscientist

Huda Akil is a Syrian–American neuroscientist whose pioneering research has contributed to the understanding of the neurobiology of emotions, including pain, anxiety, depression, and substance abuse. Akil and colleagues are best known for providing the first physiological evidence for a role of endorphins in the brain and demonstrating that endorphins are activated by stress and can cause pain inhibition.

<span class="mw-page-title-main">Endomorphin-1</span> Chemical compound

Endomorphin-1 (EM-1) (amino acid sequence Tyr-Pro-Trp-Phe-NH2) is an endogenous opioid peptide and one of the two endomorphins. It is a high affinity, highly selective agonist of the μ-opioid receptor, and along with endomorphin-2 (EM-2), has been proposed to be the actual endogenous ligand of the μ-receptor. EM-1 produces analgesia in animals and is equipotent with morphine in this regard. The gene encoding for EM-1 has not yet been identified, and it has been suggested that endomorphins could be synthesized by an enzymatic, non-ribosomal mechanism.

References

  1. ↑ Stefano GB, Ptáček R, Kuželová H, Kream RM (1515). "Endogenous morphine: up-to-date review 2011" (PDF). Folia Biologica. 58 (2): 49–56. PMID   22578954. Positive evolutionary pressure has apparently preserved the ability to synthesize chemically authentic morphine, albeit in homeopathic concentrations, throughout animal phyla. ... The apparently serendipitous finding of an opiate alkaloid-sensitive, opioid peptide-insensitive, µ3 opiate receptor subtype expressed by invertebrate immunocytes, human blood monocytes, macrophage cell lines, and human blood granulocytes provided compelling validating evidence for an autonomous role of endogenous morphine as a biologically important cellular signalling molecule (Stefano et al., 1993; Cruciani et al., 1994; Stefano and Scharrer, 1994; Makman et al., 1995). ... Human white blood cells have the ability to make and release morphine
  2. ↑ "μ receptor". IUPHAR/BPS Guide to PHARMACOLOGY. International Union of Basic and Clinical Pharmacology. 15 March 2017. Retrieved 28 December 2017. Comments: β-Endorphin is the highest potency endogenous ligand ... Morphine occurs endogenously.
  3. ↑ Poeaknapo C, Schmidt J, Brandsch M, Dräger B, Zenk MH (September 2004). "Endogenous formation of morphine in human cells". Proceedings of the National Academy of Sciences of the United States of America. 101 (39): 14091–14096. Bibcode:2004PNAS..10114091P. doi: 10.1073/pnas.0405430101 . PMC   521124 . PMID   15383669.
  4. ↑ Pilozzi A, Carro C, Huang X (December 2020). "Roles of β-Endorphin in Stress, Behavior, Neuroinflammation, and Brain Energy Metabolism". International Journal of Molecular Sciences. 22 (1): 338. doi: 10.3390/ijms22010338 . PMC   7796446 . PMID   33396962.
  5. ↑ Howlett TA, Tomlin S, Ngahfoong L, Rees LH, Bullen BA, Skrinar GS, McArthur JW (June 1984). "Release of beta endorphin and met-enkephalin during exercise in normal women: response to training". British Medical Journal. 288 (6435): 1950–1952. doi:10.1136/bmj.288.6435.1950. PMC   1442192 . PMID   6329401.
  6. ↑ Goldfarb AH, Jamurtas AZ (July 1997). "Beta-endorphin response to exercise. An update". Sports Medicine. 24 (1): 8–16. doi:10.2165/00007256-199724010-00002. PMID   9257407. S2CID   72824962.
  7. ↑ "Endorphins: What They Are and How to Boost Them". Cleveland Clinic. Retrieved 25 March 2023.
  8. ↑ "Role of endorphins discovered". PBS Online: A Science Odyssey: People and Discoveries. Public Broadcasting System. 1 January 1998. Retrieved 15 October 2008.
  9. ↑ Hughes J, Smith TW, Kosterlitz HW, Fothergill LA, Morgan BA, Morris HR (December 1975). "Identification of two related pentapeptides from the brain with potent opiate agonist activity". Nature. 258 (5536): 577–580. Bibcode:1975Natur.258..577H. doi:10.1038/258577a0. PMID   1207728. S2CID   95411.
  10. ↑ Berezniuk I, Fricker LD (2011). "Endogenous Opioids". In Pasternak GW (ed.). The Opiate Receptors. The Receptors. Totowa, NJ: Humana Press. pp. 93–120. doi:10.1007/978-1-60761-993-2_5. ISBN   978-1-60761-993-2.
  11. 1 2 3 Corbett AD, Henderson G, McKnight AT, Paterson SJ (January 2006). "75 years of opioid research: the exciting but vain quest for the Holy Grail". British Journal of Pharmacology. 147 (Suppl 1): S153–S162. doi:10.1038/sj.bjp.0706435. PMC   1760732 . PMID   16402099.
  12. 1 2 3 4 5 6 Purves D, Fitzpatrick D, Augustine GJ (2018). Neuroscience (6th ed.). New York: Sunderland. ISBN   9781605353807. OCLC   990257568.
  13. ↑ Simantov R, Snyder SH (July 1976). "Morphine-like peptides in mammalian brain: isolation, structure elucidation, and interactions with the opiate receptor". Proceedings of the National Academy of Sciences of the United States of America. 73 (7): 2515–2519. Bibcode:1976PNAS...73.2515S. doi: 10.1073/pnas.73.7.2515 . PMC   430630 . PMID   1065904.
  14. ↑ Goldstein A, Lowery PJ (September 1975). "Effect of the opiate antagonist naloxone on body temperature in rats". Life Sciences. 17 (6): 927–931. doi:10.1016/0024-3205(75)90445-2. PMID   1195988.
  15. ↑ McLaughlin PJ, Zagon IS (2013). "POMC-Derived Opioid Peptides". Handbook of Biologically Active Peptides. Elsevier. pp. 1592–1595. doi:10.1016/b978-0-12-385095-9.00217-7. ISBN   978-0-12-385095-9.
  16. ↑ Li CH, Chung D (April 1976). "Isolation and structure of an untriakontapeptide with opiate activity from camel pituitary glands". Proceedings of the National Academy of Sciences of the United States of America. 73 (4): 1145–1148. Bibcode:1976PNAS...73.1145L. doi: 10.1073/pnas.73.4.1145 . PMC   430217 . PMID   1063395.
  17. ↑ Smyth DG (May 2016). "60 YEARS OF POMC: Lipotropin and beta-endorphin: a perspective". Journal of Molecular Endocrinology. 56 (4): T13–T25. doi: 10.1530/JME-16-0033 . PMID   26903509.
  18. ↑ Loh HH, Tseng LF, Wei E, Li CH (August 1976). "beta-endorphin is a potent analgesic agent". Proceedings of the National Academy of Sciences of the United States of America. 73 (8): 2895–2898. Bibcode:1976PNAS...73.2895L. doi: 10.1073/pnas.73.8.2895 . PMC   430793 . PMID   8780.
  19. ↑ Feldberg W, Smyth DG (July 1977). "C-fragment of lipotropin--an endogenous potent analgesic peptide". British Journal of Pharmacology. 60 (3): 445–453. doi:10.1111/j.1476-5381.1977.tb07521.x. PMC   1667279 . PMID   560894.
  20. ↑ Poeaknapo C, Schmidt J, Brandsch M, Dräger B, Zenk MH (September 2004). "Endogenous formation of morphine in human cells". Proceedings of the National Academy of Sciences of the United States of America. 101 (39): 14091–14096. Bibcode:2004PNAS..10114091P. doi: 10.1073/pnas.0405430101 . PMC   521124 . PMID   15383669.
  21. ↑ Kream RM, Stefano GB (October 2006). "De novo biosynthesis of morphine in animal cells: an evidence-based model". Medical Science Monitor. 12 (10): RA207–RA219. PMID   17006413.
  22. ↑ Stein C (14 January 2016). "Opioid Receptors". Annual Review of Medicine. 67 (1): 433–451. doi: 10.1146/annurev-med-062613-093100 . PMID   26332001.
  23. ↑ Li Y, Lefever MR, Muthu D, Bidlack JM, Bilsky EJ, Polt R (February 2012). "Opioid glycopeptide analgesics derived from endogenous enkephalins and endorphins". Future Medicinal Chemistry. 4 (2): 205–226. doi:10.4155/fmc.11.195. PMC   3306179 . PMID   22300099.
  24. 1 2 Burbach JP (January 1984). "Action of proteolytic enzymes on lipotropins and endorphins: biosynthesis, biotransformation and fate". Pharmacology & Therapeutics. 24 (3): 321–354. doi:10.1016/0163-7258(84)90008-1. hdl: 1874/25178 . PMID   6087385.
  25. 1 2 Wiegant VM, Ronken E, Kovács G, De Wied D (1992). Endorphins and schizophrenia. Progress in Brain Research. Vol. 93. pp. 433–53. PMID   1480761.
  26. 1 2 Ling N, Burgus R, Guillemin R (November 1976). "Isolation, primary structure, and synthesis of alpha-endorphin and gamma-endorphin, two peptides of hypothalamic-hypophysial origin with morphinomimetic activity". Proceedings of the National Academy of Sciences of the United States of America. 73 (11): 3942–3946. Bibcode:1976PNAS...73.3942L. doi: 10.1073/pnas.73.11.3942 . PMC   431275 . PMID   1069261.
  27. 1 2 Chaudhry SR, Bhimji SS (2018). "Biochemistry, Endorphin". StatPearls. StatPearls Publishing. PMID   29262177 . Retrieved 20 February 2019.
  28. 1 2 Ambinder RF, Schuster MM (November 1979). "Endorphins: new gut peptides with a familiar face". Gastroenterology. 77 (5): 1132–1140. doi: 10.1016/S0016-5085(79)80089-X . PMID   226450.
  29. ↑ Burbach JP (January 1984). "Action of proteolytic enzymes on lipotropins and endorphins: biosynthesis, biotransformation and fate". Pharmacology & Therapeutics. 24 (3): 321–354. doi:10.1016/0163-7258(84)90008-1. hdl: 1874/25178 . PMID   6087385.
  30. ↑ Mousa SA, Shakibaei M, Sitte N, Schäfer M, Stein C (March 2004). "Subcellular pathways of beta-endorphin synthesis, processing, and release from immunocytes in inflammatory pain". Endocrinology. 145 (3): 1331–1341. doi: 10.1210/en.2003-1287 . PMID   14630714.
  31. ↑ Takahashi A, Mizusawa K (October 2013). "Posttranslational modifications of proopiomelanocortin in vertebrates and their biological significance". Frontiers in Endocrinology. 4: 143. doi: 10.3389/fendo.2013.00143 . PMC   3797980 . PMID   24146662. S2CID   18975702.
  32. 1 2 Mousa SA, Shakibaei M, Sitte N, Schäfer M, Stein C (March 2004). "Subcellular pathways of beta-endorphin synthesis, processing, and release from immunocytes in inflammatory pain". Endocrinology. 145 (3): 1331–1341. doi: 10.1210/en.2003-1287 . PMID   14630714.
  33. ↑ Loh YP, Kim T, Rodriguez YM, Cawley NX (2004). "Secretory granule biogenesis and neuropeptide sorting to the regulated secretory pathway in neuroendocrine cells". Journal of Molecular Neuroscience. 22 (1–2): 63–71. doi:10.1385/jmn:22:1-2:63. PMID   14742911. S2CID   30140731.
  34. ↑ Crine P, Gianoulakis C, Seidah NG, Gossard F, Pezalla PD, Lis M, Chrétien M (October 1978). "Biosynthesis of beta-endorphin from beta-lipotropin and a larger molecular weight precursor in rat pars intermedia". Proceedings of the National Academy of Sciences of the United States of America. 75 (10): 4719–4723. Bibcode:1978PNAS...75.4719C. doi: 10.1073/pnas.75.10.4719 . PMC   336191 . PMID   216997.
  35. ↑ Goldstein A (September 1976). "Opioid peptides endorphins in pituitary and brain". Science. 193 (4258): 1081–1086. Bibcode:1976Sci...193.1081G. doi:10.1126/science.959823. PMID   959823.
  36. ↑ Binder W, Mousa SA, Sitte N, Kaiser M, Stein C, Schäfer M (July 2004). "Sympathetic activation triggers endogenous opioid release and analgesia within peripheral inflamed tissue". The European Journal of Neuroscience. 20 (1): 92–100. doi:10.1111/j.1460-9568.2004.03459.x. PMID   15245482. S2CID   33125103.
  37. ↑ "Electroacupuncture - an overview | ScienceDirect Topics".
  38. ↑ Sprouse-Blum AS, Smith G, Sugai D, Parsa FD (March 2010). "Understanding endorphins and their importance in pain management". Hawaii Medical Journal. 69 (3): 70–71. PMC   3104618 . PMID   20397507.
  39. ↑ Dfarhud D, Malmir M, Khanahmadi M (November 2014). "Happiness & Health: The Biological Factors- Systematic Review Article". Iranian Journal of Public Health. 43 (11): 1468–1477. PMC   4449495 . PMID   26060713.
  40. ↑ Dunbar RI, Baron R, Frangou A, Pearce E, van Leeuwen EJ, Stow J, et al. (March 2012). "Social laughter is correlated with an elevated pain threshold". Proceedings. Biological Sciences. 279 (1731): 1161–1167. doi:10.1098/rspb.2011.1373. PMC   3267132 . PMID   21920973.
  41. ↑ Boecker H, Sprenger T, Spilker ME, Henriksen G, Koppenhoefer M, Wagner KJ, et al. (November 2008). "The runner's high: opioidergic mechanisms in the human brain". Cerebral Cortex. 18 (11): 2523–2531. doi: 10.1093/cercor/bhn013 . PMID   18296435.
  42. ↑ Kolata G (27 March 2008). "Yes, Running Can Make You High". The New York Times. ISSN   0362-4331 . Retrieved 26 May 2016.
  43. ↑ Reynolds G (10 March 2021). "Getting to the Bottom of the Runner's High". The New York Times. ISSN   0362-4331 . Retrieved 16 March 2021.
  44. ↑ Anderson E, Shivakumar G (23 April 2013). "Effects of exercise and physical activity on anxiety". Frontiers in Psychiatry. 4: 27. doi: 10.3389/fpsyt.2013.00027 . PMC   3632802 . PMID   23630504.
  45. ↑ Freimuth M, Moniz S, Kim SR (October 2011). "Clarifying exercise addiction: differential diagnosis, co-occurring disorders, and phases of addiction". International Journal of Environmental Research and Public Health. 8 (10): 4069–4081. doi: 10.3390/ijerph8104069 . PMC   3210598 . PMID   22073029.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.